| ALLERGAN, Inc. (NY:AGN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $58.65 | 52 Week High | $60.85 | ||
| Open | $58.13 | 52 Week Low | $28.95 | ||
| Day High | $58.82 | P/E | 32.39 | ||
| Day Low | $58.13 | EPS | $1.81 | ||
| Volume | 1,239,540 | ||||
| More AGN Info: Chart SEC Filings Profile Historical Options | |||||
Allergan, Inc. develops and commercializes pharmaceutical and medical device products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, and other specialty markets worldwide.
David E.I. Pyott - Chairman, CEO
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| ARM | 11 | GR | 11 |
| RAND | 10 | SWN | 10 |
| TLVT | 10 | CL | 10 |
| RDSA | 10 | MEO | 10 |
| PG | 10 | EVN | 10 |
| XB | 10 | SAN | 10 |
No comments are currently available.
on Jul 26, 2009
at 03:45 PM allergan With their cosmetic and new eye and urinary meds I see Allergan going to 72
Article: Citi Upgrades Allergan (AGN) to Buy